Comparing Pegvisomant vs Sandostatin LAR Depot
Pegvisomant | Sandostatin LAR Depot (octreotide) |
|
---|
Pegvisomant | Sandostatin LAR Depot (octreotide) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Acromegaly. Pegvisomant may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Carcinoid Tumor, Acromegaly, Vasoactive Intestinal Peptide Tumor. Sandostatin LAR Depot may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||
More about Pegvisomant | More about Sandostatin LAR Depot (octreotide) | ||||||||
Ratings & Reviews | |||||||||
Pegvisomant has an average rating of 5.8 out of 10 from a total of 4 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 50% reported a negative effect. |
Sandostatin LAR Depot has an average rating of 8.7 out of 10 from a total of 7 ratings on Drugs.com. 86% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Pegvisomant side effects |
View all Sandostatin LAR Depot side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
Lower cost generic approved | ||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Sandostatin LAR Depot prices |
||||||||
Dosage Forms | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
Somavert | Other octreotide brands include: Bynfezia Pen, Mycapssa, Sandostatin | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
144 hours |
1.5 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 74 drugs are known to interact with Pegvisomant:
|
A total of 167 drugs are known to interact with Sandostatin LAR Depot:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
N/A |
N/A |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
N/A |
|||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Sandostatin
Sandostatin is used to treat acromegaly and to reduce flushing episodes and watery diarrhea caused ...
Sandostatin LAR Depot
Sandostatin LAR Depot is used for acromegaly, carcinoid tumor, vasoactive intestinal peptide tumor
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Parlodel
Parlodel is used for acromegaly, hyperprolactinemia, parkinson's disease
Cycloset
Cycloset is used to treat Type 2 Diabetes. Learn about side effects, interactions and indications.
Somatuline Depot
Somatuline Depot is used as a long-term treatment for acromegaly. Learn about side effects ...
Signifor
Signifor (pasireotide) is a man-made protein that is similar to somatostatin and is used to treat ...
Mycapssa
Mycapssa (octreotide) is used for the treatment of acromegaly. Includes Mycapssa side effects ...
Bromocriptine
Bromocriptine is used for acromegaly, hyperprolactinemia, parkinson's disease, tardive dyskinesia ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.